Tamoxifen, raloxifene cut breast cancer risk in half
Tuesday, April 20, 2010 - 10:56
in Health & Medicine
Women at high risk can take either drug as preventive therapy, researchers in a seven-year study say. Two drugs taken by women at high risk for breast cancer — tamoxifen and raloxifene — both reduce the risk of the disease by about 50% in high-risk post-menopausal women while they are taking the medications, researchers said Monday. The benefits of raloxifene fall off more...
Read the whole article on LA Times - Health
More from LA Times - Health
Related
- High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study findsWed, 2 Dec 2009, 10:06:13 EST
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT
- Taking tamoxifen to prevent breast cancer can save lives and money Mon, 14 Mar 2011, 0:32:14 EDT
- Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen Wed, 6 Apr 2011, 8:37:27 EDT